These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34716650)

  • 1. Diffuse erythema and peeling during dupilumab therapy in a patient with atopic dermatitis.
    Cheng B; Yin M; Dou X
    Dermatol Ther; 2021 Nov; 34(6):e15183. PubMed ID: 34716650
    [No Abstract]   [Full Text] [Related]  

  • 2. Dupilumab-Induced Extrafacial Paradoxical Persistent Erythema in an Atopic Dermatitis Patient.
    Juan-Carpena G; Palazón-Cabanes JC; Bañuls J; Docampo-Simón A; Sánchez-Pujol MJ; Niveiro M; Silvestre JF
    Dermatitis; 2021 Oct; 32(1S):e83-e85. PubMed ID: 34405837
    [No Abstract]   [Full Text] [Related]  

  • 3. Pustular Psoriasis Appearing Induced by Dupilumab Therapy in a Patient With Atopic Dermatitis.
    Jia X; Li C; Wu J; Liu Q
    J Drugs Dermatol; 2022 Mar; 21(3):311-312. PubMed ID: 35254760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angioedema: A potential complication of dupilumab in atopic dermatitis.
    Fritz AL; Lacy FA; Morrell DS
    Pediatr Dermatol; 2021 Jan; 38(1):237-238. PubMed ID: 33099796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A paradoxical head and neck erythema: an adverse event due to dupilumab in adult patients with atopic dermatitis.
    Russo F; Rizzo A; Santi F; Lamberti A; Lazzeri L; Flori ML; Rubegni P
    Int J Dermatol; 2022 Jun; 61(6):e204-e206. PubMed ID: 34480761
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune Thrombocytopenic Purpura in a Patient with Atopic Dermatitis Treated with Dupilumab.
    Frey S; Kendziora B; Holch JW; Lindner L; French LE; Wollenberg A
    Acta Derm Venereol; 2021 Mar; 101(3):adv00409. PubMed ID: 33349889
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of dirty neck in severe and diffuse atopic dermatitis successfully treated with dupilumab.
    Patruno C; Ferrillo M; Fabbrocini G; Napolitano M
    Dermatol Ther; 2021 Jan; 34(1):e14556. PubMed ID: 33205854
    [No Abstract]   [Full Text] [Related]  

  • 8. Dupilumab facial redness: Clinical characteristics and proposed treatment in a cohort.
    Ordóñez-Rubiano MF; Casas M; Balaguera-Orjuela V
    Dermatol Ther; 2021 Nov; 34(6):e15140. PubMed ID: 34549488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facial and neck erythema associated with dupilumab treatment: A systematic review.
    Jo CE; Finstad A; Georgakopoulos JR; Piguet V; Yeung J; Drucker AM
    J Am Acad Dermatol; 2021 May; 84(5):1339-1347. PubMed ID: 33428978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of dupilumab-induced reverse psoriasis in a patient with atopic dermatitis.
    Fan J; Zhang L; Lu Y; Zhou P
    Dermatol Ther; 2022 Apr; 35(4):e15345. PubMed ID: 35094480
    [No Abstract]   [Full Text] [Related]  

  • 11. Two differing presentations of periocular dermatitis as a side effect of dupilumab for atopic dermatitis.
    Yamane MLM; Belsito DV; Glass LRD
    Orbit; 2019 Oct; 38(5):390-394. PubMed ID: 30628518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Enlargement of Vitiligo Vulgaris after Initiation of Dupilumab for Atopic Dermatitis: A Case Report.
    Takeoka S; Kamata M; Yokoi I; Takehara A; Tada Y
    Acta Derm Venereol; 2021 Oct; 101(10):adv00581. PubMed ID: 34694417
    [No Abstract]   [Full Text] [Related]  

  • 13. Improvement of atopic dermatitis and IgA nephropathy in a patient treated by dupilumab.
    Tanczosova M; Arenberger P; Rychlik I; Arenbergerova M; Gkalpakiotis S
    Dermatol Ther; 2021 Jan; 34(1):e14708. PubMed ID: 33368910
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe atopic dermatitis: Dupilumab is not just safer, but more efficient.
    Giavina-Bianchi M; Rizzo LV; Giavina-Bianchi P
    Allergol Immunopathol (Madr); 2020; 48(6):792-797. PubMed ID: 32249095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dupilumab ocular surface disease occurs predominantly in patients receiving dupilumab for atopic dermatitis: A multi-institution retrospective chart review.
    Waldman RA; DeWane ME; Sloan SB; King B; Grant-Kels JM
    J Am Acad Dermatol; 2021 Sep; 85(3):735-736. PubMed ID: 31325553
    [No Abstract]   [Full Text] [Related]  

  • 16. Facial erythema during dupilumab treatment for atopic dermatitis successfully remedied with topical crisaborole ointment: A case report.
    Tsai YC; Tsai TF
    Dermatol Ther; 2022 Nov; 35(11):e15843. PubMed ID: 36124378
    [No Abstract]   [Full Text] [Related]  

  • 17. Transitory Dissemination of Molluscum Contagiosum in a Patient Treated with Dupilumab for Atopic Dermatitis.
    Ferrucci S; Tavecchio S; Veraldi S; Berti E; Benzecry V
    Acta Derm Venereol; 2020 Jul; 100(14):adv00207. PubMed ID: 32556344
    [No Abstract]   [Full Text] [Related]  

  • 18. Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis.
    Marcant P; Balayé P; Merhi R; Jendoubi F; Nosbaum A; Raison-Peyron N; Du-Thanh A; Lasek A; Ferrier le Bouedec MC; Tetart F; Valois A; Barbarot S; Soria A; Jachiet M; Staumont-Sallé D;
    J Eur Acad Dermatol Venereol; 2021 Jun; 35(6):e394-e396. PubMed ID: 33594731
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adults.
    Patruno C; Stingeni L; Hansel K; Ferrucci SM; Tavecchio S; Fabbrocini G; Nisticò SP; Foti C; De Prezzo S; Napolitano M
    Dermatol Ther; 2020 May; 33(3):e13290. PubMed ID: 32125741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupilumab for the treatment of atopic dermatitis in transplant patients: Two case reports and literature review.
    Napolitano M; Nocerino M; Picone V; Martora F; Fabbrocini G; Dastoli S; Patruno C
    Dermatol Ther; 2022 Apr; 35(4):e15324. PubMed ID: 35048522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.